MAIA Biotechnology, Inc. (MAIA)

USD 1.94

(-11.82%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue - - - - -
Gross Profit - - - - -
Operating Expenses 20.18 Million 15.86 Million 7.74 Million 6.97 Million 6.92 Million
Selling, General and Administrative Expenses 9.07 Million 6.14 Million 4.28 Million 5.56 Million 5 Million
Research and Development Expenses 11.11 Million 8.61 Million 3.45 Million 1.41 Million 1.91 Million
Other Expenses - 1.09 Million - - -
Cost and Expenses 20.18 Million 15.86 Million 7.74 Million 6.97 Million 6.92 Million
Operating Income -20.18 Million -16.17 Million -7.78 Million -6.97 Million -6.92 Million
Interest Expense - 6967.00 827.53 Thousand 32.22 Thousand -
Income Tax Expense - 36.68 Thousand 707.53 Thousand -291.04 Thousand -435.25 Thousand
Earnings before Tax -19.77 Million -15.76 Million -12.57 Million -6.95 Million -6.92 Million
Net Income -19.77 Million -15.8 Million -13.28 Million -6.66 Million -6.49 Million
Earnings Per Share Basic -1.49 -1.70 -1.25 -0.63 -0.61
Earnings Per Share Diluted -1.49 -1.70 -1.25 -0.63 -0.61
Weighted Average Shares Outstanding 13.26 Million 9.27 Million 10.63 Million 10.63 Million 10.63 Million
Weighted Average Shares Outstanding (Diluted) 13.26 Million 9.27 Million 10.63 Million 10.63 Million 10.63 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -20.18 Million -16.17 Million - - 242.00
Earnings Before Tax Margin - - - - -

Income Statement Charts